Order Article Reprints

Rungmaitree S, Thepthai C, Toh ZQ, Musiwiraphat N, Maleesatharn A, Rermruay R, Sungkate S, Phongsamart W, Lapphra K, Wittawatmongkol O, et al. Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution. Vaccines. 2022; 10(1):118. https://doi.org/10.3390/vaccines10010118

Rungmaitree, Supattra, Charin Thepthai, Zheng Quan Toh, Noppasit Musiwiraphat, Alan Maleesatharn, Rattanachai Rermruay, Sathida Sungkate, Wanatpreeya Phongsamart, Keswadee Lapphra, Orasri Wittawatmongkol, and et al. 2022. "Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution" Vaccines 10, no. 1: 118. https://doi.org/10.3390/vaccines10010118

Rungmaitree, S., Thepthai, C., Toh, Z. Q., Musiwiraphat, N., Maleesatharn, A., Rermruay, R., Sungkate, S., Phongsamart, W., Lapphra, K., Wittawatmongkol, O., Dharakul, T., Mulholland, K., & Chokephaibulkit, K. (2022). Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution. Vaccines, 10(1), 118. https://doi.org/10.3390/vaccines10010118